Stay updated on Atezolizumab Combo in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now displays an updated site revision number (v3.5.2 instead of v3.5.0). This appears to be a system/version update rather than a change to the trial record details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Adverse Events, Baseline Characteristics, Participant Flow, Outcome Measures, and Study Status sections to the record; removed an earlier version entry.SummaryDifference0.6%

- Check33 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the study record history.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed from the change log.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.4.2 was added to the version history and Revision: v3.4.1 was removed. This update appears to reflect a site release rather than a change to trial data.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.1 is displayed in the page footer, replacing the previous v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab Combo in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page.